AI Science Tracker

Machine learning identifies a high-risk diabetic cardiomyopathy phenotype linked to future heart failure

University of Texas Southwestern Medical Center; Texas Heart Institute; Houston Methodist DeBakey Heart & Vascular Center; Duke University; National Heart Centre Singapore; University of Toronto; University of Colorado; Massachusetts General Hospital · 6 Sep 2024 · medicine

Discovery

Machine learning identifies a high-risk diabetic cardiomyopathy phenotype linked to future heart failure

Unsupervised clustering of 25 echocardiographic and biomarker variables in 1,199 ARIC participants with diabetes identified three phenogroups; the group with the greatest cardiac remodelling and neurohormonal-stress abnormalities had 12.1% five-year heart-failure incidence, versus 4.6% and 3.1% in the other groups. A deep-neural-network classifier trained to recognize this phenotype identified corresponding high-risk groups in the external CHS cohort (n=802) and UT Southwestern EHR cohort (n=5,071); phenotype classification was associated with incident heart failure in both.

Technology: Unsupervised hierarchical clustering and a deep neural network (DeepNN) classifier, with random forest variable-importance analysis

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: Unsupervised clustering of 25 echocardiographic and biomarker variables in 1,199 ARIC participants with diabetes identified three phenogroups; the group with the greatest cardiac remodelling and neurohormonal-stress abnormalities had 12.1% five-year heart-failure incidence, versus 4.6% and 3.1% in the other groups.
  • Still unknown: The cohorts were observational; association with future heart failure does not establish that model-guided intervention improves outcomes. The phenotype is an operational study definition, not a universally accepted diagnostic threshold. The authors describe potential preventive use, but it was not tested. The cohorts were external validations rather than prospective deployment trials.
  • AI role: The authors used unsupervised hierarchical clustering of echocardiography and cardiac biomarkers to define outcome-associated diabetic-cardiomyopathy phenogroups, then trained and externally validated a DeepNN classifier to recognize the high-risk phenotype. Random forest permutation importance prioritized NT-proBNP, left-ventricular mass, Doppler measurements, left-atrial dimension and LV end-diastolic volume.

Evidence sources: https://onlinelibrary.wiley.com/doi/10.1002/ejhf.3443

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 88 of works of the same type, year and subfield (OpenAlex work metrics, 8 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.